Treatment Outcomes and Toxicities of Multiple Tyrosin Kinase Inhibitors for Metastatic Medullary Thyroid Cancer: A Case Series

Treatment Outcomes and Toxicities of Multiple Tyrosin Kinase Inhibitors for Metastatic Medullary Thyroid Cancer: A Case Series

<b>Background</b>: The current possible treatments of advanced medullary carcinoma (MTC) include different drugs belonging to the class of tyrosine kinase inhibitors (TKIs): vandetanib, cabozantinb, and selpercatinib. Although the effects of these TKIs have been well described in clinica...

Full description

Saved in:
Bibliographic Details
Main Authors: Marilda Mormando, Rosa Lauretta, Giulia Puliani, Marta Bianchini, Maria Elena Spoltore, Marialuisa Appetecchia
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Biomedicines
Subjects:
medullary thyroid cancer
cabozantinib
vandetanib
selpercatinib
adverse events
lung cavitations
Online Access:https://www.mdpi.com/2227-9059/12/12/2923
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items